Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study
Çharles N. Bernstein(University of Manitoba), Paul Moayyedi(McMaster University Medical Centre), Anthony Otley(Izaak Walton Killam Health Centre), Mark Borgaonkar, Gilaad G. Kaplan(University of Calgary), Alain Bitton(McGill University Health Centre), Michelle Buresi(University of Calgary), Zoann Nugent(Health Sciences Centre), Levinus A. Dieleman(University of North Carolina at Chapel Hill), Kenneth Croitoru(University of Toronto), Deborah A. Marshall(University of Calgary), Sanjay K. Murthy(University of Ottawa), Brian Bressler(University of British Columbia), Lesley A. Graff(Manitoba Health), Jennifer Jones(Dalhousie University), Sacha Sidani(Université de Montréal), Remo Panaccione(University of Calgary), Aida Fernandes(Crohn's and Colitis Canada), Stephen Vanner(Queen's University)
Cited by 8
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
|BMJ|1996|3.7k
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k